Latest news
What Does Merck (MRK) Lose From Ending Its Late Stage Lung Cancer Trial? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:37:53 GMTMerck announces Health Canada approval of KEYTRUDA for adults with MIBC - tipranks.comtipranks.com · Wed, 05 Aug 2026 19:30:07 GMTHealth Canada Approves KEYTRUDA® for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 15:00:00 GMTSeaweed extract shown to relieve prostate symptoms - Yahoo! Finance CanadaYahoo! Finance Canada · Mon, 27 Jul 2026 07:00:00 GMT